Analyst Viewpoint
Increase in focus on early profiling during organ transplantation and rise in incidence of chronic kidney disorders are propelling the transplant diagnostics market size. Early profiling and organ transplant monitoring are gaining traction among healthcare professionals to minimize the risk of rejection and improve overall transplant outcomes.
Transplantation is a viable and often preferred treatment option for patients suffering from chronic kidney diseases. R&D in noninvasive transplant diagnostic methods, immunosuppressive medications, and post-transplant care is likely to offer lucrative opportunities to players in the global transplant diagnostics industry. Vendors are developing novel assays and antigen products to expand their product portfolio.
Transplant diagnostics are tests and procedures performed before, during, and after organ transplantation. They ensure the compatibility between the donor organ and the recipient's immune system. Rise in risk of organ rejection is boosting demand for transplant diagnostics.
Organizations across the globe are promoting organ harvesting, which is fueling the number of donated organs. Next Generation Sequencing (NGS) technology has had a significant impact on organ transplantation. NGS is utilized for high-resolution typing of Human Leukocyte Antigens (HLA), which are crucial for immune system compatibility.
High costs associated with transplant diagnostic procedures, such as histocompatibility tests, genomic profiling, and blood profiling, are projected to limit the transplant diagnostics market growth in the near future. These procedures are conducted through exclusive molecular diagnostic platforms, which leads to high costs. Moreover, there are various challenges in integrating these technologies with traditional PCR/NGS instruments. There is a noticeable gap between the number of organs needed and the number of organs donated. These factors are estimated to restrain the transplant diagnostics industry progress during the forecast period.
Healthcare professionals are relentlessly investigating the potential of biomarkers in organ transplantation for improving patient outcomes and the overall success of transplant procedures. Biomarkers provide valuable information about the status of the transplanted organ and the recipient's immune response.
Rise in focus on early profiling during organ transplantation is boosting demand for transplant diagnostics. Early profiling involves the systematic assessment of various factors including genetic, molecular, and clinical markers. It helps healthcare professionals to draft patient-specific transplant procedures and post-transplant care. Hence, growth in focus on demonstration and validation of the clinical utility of biomarkers is driving the transplant diagnostics market trajectory.
Chronic kidney disease implies a progressive condition that affects more than 10% of the global population. The disease is more prevalent among women, elderly people, and those suffering from hypertension and diabetes mellitus. The adversities related to chronic kidney diseases require improvised efforts for better treatment. Kidney transplantation kidney transplantation improves the quality of life compared to long-term dialysis. As per the National Institute of Diabetes and Digestive and Kidney Disequencingases (NIDDK), 661,000 people in the U.S. suffer from kidney failure. Thus, surge in cases of chronic kidney disease is driving the transplant diagnostics market expansion.
According to the latest transplant diagnostics market trends, North America held largest share in 2022. Rise in investment in R&D for organ transplantation is fueling the market dynamics of the region. According to The National Institute of Health, funding for research in transplantation was US$ 735 Mn in 2022. Additionally, as per the Organ Donation Statistics, over 40,000 organ transplantations were conducted in the U.S. in 2021.
According to the latest transplant diagnostics market forecast, the industry in Europe is estimated to grow at a steady pace during the forecast period. Rise in expenditure in healthcare sector and availability of smoother applications in all transplantation processes and donor-recipient relationships are boosting the market landscape in Europe.
Increase in investment in advanced healthcare infrastructure is propelling the transplant diagnostics market value in Asia Pacific. India and China are major markets for transplant diagnostics due to growth in prevalence of chronic diseases. However, cultural considerations in Hong Kong, Japan, and Philippines may impact attitudes toward organ transplantation. People in these countries emphasize ancestor worship and respect for the deceased and do not believe in parting with their organs after death.
Major players are investing in R&D and launch of new products to expand their product portfolio and increase their transplant diagnostics market share. Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Becton, Dickinson, and Company, Ortho Clinical Diagnostics, Immucor, Inc., Illumina, Inc., Siemens Healthineers, and Agilent Technologies are major companies operating in this market.
These companies have been profiled in the transplant diagnostics industry report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 1.2 Bn |
| Market Forecast (Value) in 2031 | US$ 2.3 Bn |
| Growth Rate (CAGR) | 7.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.2 Bn in 2022
It is projected to grow at a CAGR of 7.7% from 2023 to 2031
Increase in focus on early profiling during organ transplantation and rise in incidence of chronic kidney disorders
North America is estimated to dominate in the next few years
Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Becton, Dickinson, and Company, Ortho Clinical Diagnostics, Immucor, Inc., Illumina, Inc., Siemens Healthineers, and Agilent Technologies
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transplant Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Screening, 2017–2031
6.3.1. Pre-transplant Diagnostics
6.3.2. Post-transplant Diagnostics
6.4. Market Attractiveness, by Screening
7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017–2031
7.3.1. Molecular Assay
7.3.2. Non-molecular Assay
7.3.3. 7.4 Market Attractiveness, by Technique
8. Global Transplant Diagnostics Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Solid Organ Transplantation
8.3.1.1. Kidney
8.3.1.2. Liver
8.3.1.3. Heart
8.3.1.4. Lungs
8.3.1.5. Pancreas
8.3.1.6. Small Bowel
8.3.2. Stem Cell Transplantation
8.4. Market Attractiveness, by Application
9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Products & Services, 2017–2031
9.3.1. Reagents & Consumables
9.3.2. Instruments
9.3.3. Software & Services
9.4. Market Attractiveness, by Products & Services
10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals & Transplant Centers
10.3.2. Research Laboratories
10.3.3. Others
10.4. Market Attractiveness, by End-user
11. Global Transplant Diagnostics Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region
12. North America Transplant Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Screening, 2017–2031
12.2.1. Pre-transplant Diagnostics
12.2.2. Post-transplant Diagnostics
12.3. Market Attractiveness, by Screening
12.4. Market Value Forecast, by Technique, 2017–2031
12.4.1. Molecular Assay
12.4.2. Non-molecular Assay
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Application, 2017–2031
12.6.1. Solid Organ Transplantation
12.6.1.1. Kidney
12.6.1.2. Liver
12.6.1.3. Heart
12.6.1.4. Lungs
12.6.1.5. Pancreas
12.6.1.6. Small Bowel
12.6.2. Stem Cell Transplantation
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by Products & Services, 2017–2031
12.8.1. Reagents & Consumables
12.8.2. Instruments
12.8.3. Software & Services
12.9. Market Attractiveness, by Products & Services
12.10. Market Value Forecast, by End-user, 2017–2031
12.10.1. Hospitals & Transplant Centers
12.10.2. Research Laboratories
12.10.3. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Screening
12.13.2. By Technique
12.13.3. By Application
12.13.4. By Products & Services
12.13.5. By End-user
12.13.6. By Country
13. Europe Transplant Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Screening, 2017–2031
13.2.1. Pre-transplant Diagnostics
13.2.2. Post-transplant Diagnostics
13.3. Market Attractiveness, by Screening
13.4. Market Value Forecast, by Technique, 2017–2031
13.4.1. Molecular Assay
13.4.2. Non-molecular Assay
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Application, 2017–2031
13.6.1. Solid Organ Transplantation
13.6.1.1. Kidney
13.6.1.2. Liver
13.6.1.3. Heart
13.6.1.4. Lungs
13.6.1.5. Pancreas
13.6.1.6. Small Bowel
13.6.2. Stem Cell Transplantation
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by Products & Services, 2017–2031
13.8.1. Reagents & Consumables
13.8.2. Instruments
13.8.3. Software & Services
13.9. Market Attractiveness, by Products & Services
13.10. Market Value Forecast, by End-user, 2017–2031
13.10.1. Hospitals & Transplant Centers
13.10.2. Research Laboratories
13.10.3. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Screening
13.13.2. By Technique
13.13.3. By Application
13.13.4. By Products & Services
13.13.5. By End-user
13.13.6. By Country/Sub-region
14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Screening, 2017–2031
14.2.1. Pre-transplant Diagnostics
14.2.2. Post-transplant Diagnostics
14.3. Market Attractiveness, by Screening
14.4. Market Value Forecast, by Technique, 2017–2031
14.4.1. Molecular Assay
14.4.2. Non-molecular Assay
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Application, 2017–2031
14.6.1. Solid Organ Transplantation
14.6.1.1. Kidney
14.6.1.2. Liver
14.6.1.3. Heart
14.6.1.4. Lungs
14.6.1.5. Pancreas
14.6.1.6. Small Bowel
14.6.2. Stem Cell Transplantation
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by Products & Services, 2017–2031
14.8.1. Reagents & Consumables
14.8.2. Instruments
14.8.3. Software & Services
14.9. Market Attractiveness, by Products & Services
14.10. Market Value Forecast, by End-user, 2017–2031
14.10.1. Hospitals & Transplant Centers
14.10.2. Research Laboratories
14.10.3. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Screening
14.13.2. By Technique
14.13.3. By Application
14.13.4. By Products & Services
14.13.5. By End-user
14.13.6. By Country/Sub-region
15. Latin America Transplant Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Screening, 2017–2031
15.2.1. Pre-transplant Diagnostics
15.2.2. Post-transplant Diagnostics
15.3. Market Attractiveness, by Screening
15.4. Market Value Forecast, by Technique, 2017–2031
15.4.1. Molecular Assay
15.4.2. Non-molecular Assay
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Application, 2017–2031
15.6.1. Solid Organ Transplantation
15.6.1.1. Kidney
15.6.1.2. Liver
15.6.1.3. Heart
15.6.1.4. Lungs
15.6.1.5. Pancreas
15.6.1.6. Small Bowel
15.6.2. Stem Cell Transplantation
15.7. Stem Cell Transplantation Market Attractiveness, by Application
15.8. Market Value Forecast, by Products & Services, 2017–2031
15.8.1. Reagents & Consumables
15.8.2. Instruments
15.8.3. Software & Services
15.9. Market Attractiveness, by Products & Services
15.10. Market Value Forecast, by End-user, 2017–2031
15.10.1. Hospitals & Transplant Centers
15.10.2. Research Laboratories
15.10.3. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Screening
15.13.2. By Technique
15.13.3. By Application
15.13.4. By Products & Services
15.13.5. By End-user
15.13.6. By Country/Sub-region
16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Screening, 2017–2031
16.2.1. Pre-transplant Diagnostics
16.2.2. Post-transplant Diagnostics
16.3. Market Attractiveness, by Screening
16.4. Market Value Forecast, by Technique, 2017–2031
16.4.1. Molecular Assay
16.4.2. Non-molecular Assay
16.5. Market Attractiveness, by Technique
16.6. Market Value Forecast, by Application, 2017–2031
16.6.1. Solid Organ Transplantation
16.6.1.1. Kidney
16.6.1.2. Liver
16.6.1.3. Heart
16.6.1.4. Lungs
16.6.1.5. Pancreas
16.6.1.6. Small Bowel
16.6.2. Stem Cell Transplantation
16.7. Market Attractiveness, by Application
16.8. Market Value Forecast, by Products & Services, 2017–2031
16.8.1. Reagents & Consumables
16.8.2. Instruments
16.8.3. Software & Services
16.9. Market Attractiveness, by Products & Services
16.10. Market Value Forecast, by End-user, 2017–2031
16.10.1. Hospitals & Transplant Centers
16.10.2. Research Laboratories
16.10.3. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Screening
16.13.2. By Technique
16.13.3. By Application
16.13.4. By Products & Services
16.13.5. By End-user
16.13.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Bio-Rad laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Qiagen N.V.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. F. Hoffmann-La Roche AG
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Thermo Fisher Scientific, Inc.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Becton, Dickinson and Company
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Ortho Clinical Diagnostics
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Immucor, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Illumina, Inc.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Siemens Healthineers (Siemens AG)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Agilent Technologies
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
List of Tables
Table 01: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 02: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 03: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 04: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 06: Global Transplant Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 08: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 09: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 11: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 12: North America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 15: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 16: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 17: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 18: Europe Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 19: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 21: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 22: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 24: Asia Pacific Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 27: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 28: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 29: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 30: Latin America Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 31: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 32: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Screening, 2017–2031
Table 33: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Technique, 2017–2031
Table 34: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 35: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by Products & Services, 2017–2031
Table 36: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Transplant Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Transplant Diagnostics Market Revenue (US$ Mn), by Screening, 2022
Figure 03: Global Transplant Diagnostics Market Value Share, by Screening, 2022
Figure 04: Global Transplant Diagnostics Market Revenue (US$ Mn), by Technique, 2022
Figure 05: Global Transplant Diagnostics Market Value Share, by Technique, 2022
Figure 06: Global Transplant Diagnostics Market Revenue (US$ Mn), by Application, 2022
Figure 07: Global Transplant Diagnostics Market Value Share, by Application, 2022
Figure 08: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
Figure 09: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
Figure 10: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 11: Global Transplant Diagnostics Market Value Share, by End-user, 2022
Figure 12: Global Transplant Diagnostics Market Value Share, by Region, 2022
Figure 13: Global Transplant Diagnostics Market Value (US$ Mn) Forecast, 2017–2031
Figure 14: Global Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 15: Global Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023-2031
Figure 16: Global Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 17: Global Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023-2031
Figure 18: Global Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 19: Global Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 20: Global Transplant Diagnostics Market Revenue (US$ Mn), by Products & Services, 2022
Figure 21: Global Transplant Diagnostics Market Value Share, by Products & Services, 2022
Figure 22: Global Transplant Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 23: Global Transplant Diagnostics Market Value Share, by End-user, 2022
Figure 24: Global Transplant Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
Figure 25: Global Transplant Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
Figure 26: North America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 27: North America Transplant Diagnostics Market Attractiveness Analysis, by Country, 2023–2031
Figure 28: North America Transplant Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
Figure 29: North America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 30: North America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 31: North America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: North America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 33: North America Transplant Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 34: North America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031
Figure 35: North America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031
Figure 36: North America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 37: North America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 38: North America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 39: Europe Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 40: Europe Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 41: Europe Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Europe Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 43: Europe Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 44: Europe Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 45: Europe Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 46: Europe Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Europe Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031
Figure 48: Europe Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031
Figure 49: Europe Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 50: Europe Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 51: Europe Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Asia Pacific Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 53: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 55: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 56: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 57: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 59: Asia Pacific Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031
Figure 61: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031
Figure 62: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 63: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 64: Asia Pacific Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 65: Latin America Transplant Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 66: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 67: Latin America Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 68: Latin America Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 69: Latin America Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 70: Latin America Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 71: Latin America Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 72: Latin America Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 73: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031
Figure 74: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031
Figure 75: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 76: Latin America Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 77: Latin America Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 78: Middle East & Africa Transplant Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 79: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 80: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 81: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Screening, 2022 and 2031
Figure 82: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Technique, 2022 and 2031
Figure 83: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 84: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by Products & Services, 2022 and 2031
Figure 85: Middle East & Africa Transplant Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 86: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Screening, 2023–2031
Figure 87: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Technique, 2023–2031
Figure 88: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 89: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by Products & Services, 2023–2031
Figure 90: Middle East & Africa Transplant Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Transplant Diagnostics Market
